“…As such, thrombotic events contribute to a variety of clinical sequelae encompassing ischemic heart disease and stroke [ 2 , 6 , 11 ]. Moreover, several hemolytic conditions, such as sickle cell disease (SCD) [ 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 ], hemolytic uremic syndrome [ 25 , 26 ], hemoglobinuria [ 27 , 28 ], hemolytic transfusion reactions [ 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 ], hemorrhage [ 33 , 37 , 38 , 39 , 40 , 41 , 42 ], and cardiac surgery [ 43 , 44 ], were reported to manifest thrombotic complications as thrombosis, hypercoagulability, and vasculopathy [ 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 ]. In adult SCD patients, venous thromboembolism (VTE) is even one of the leading causes of death [ 57 , 58 ].…”